William Guyer - 02 Feb 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Development Officer
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for William Guyer
Issuer symbol
CORT
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 18:41:26 UTC
Previous filing
03 Sep 2021
Next filing
15 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 02 Feb 2022 Common Stock 100,000 $19.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026.